Form4insider filings, from the source

SEC Form 4 · accession 0001140361-16-088066

Organogenesis Holdings Inc. · ORGO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Thompson Dean
Officer — Executive Chairman · Director · 10% Owner
David F Burgstahler
Officer — President and CEO · Director · 10% Owner
Period of report
Nov 25, 2016
Accepted (ET)
Nov 29, 2016 · 4:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001661181

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Class B Ordinary SharesF2,F3,F4,F5,F1—Nov 25, 2016J700,000D——Class A Ordinary Shares700,0006,040,000D
Class B Ordinary SharesF3,F4,F5,F1—Nov 28, 2016S161,180D——Class A Ordinary Shares161,1805,878,820D

Explanation of responses

Remarks

Exhibit 99.1 Joint Filer Information, incorporated herein by reference.